Neurocognitive deficits are a core feature of schizophrenia. Deficits covering a wide range of functions have been well documented. However there is still a lack of longitudinal studies regarding the development of neurocognitive impairment. The current study examined the effect of time in longterm treated patients with schizophrenia and healthy controls on cognitive functions. A neurocognitive test-battery was administered to 36 patients and 46 controls on two occasions with approximately 4.5 years interval. Patients performed significantly worse on all measures on both occasions. The only significant decline over time was the ability to shift mental set between different rules or categories (measured by Trail Making Test B). This decline was present in both patients and controls. Improvement on attention (tested by Continuous Performance Test) was found in patients only and improvement on verbal learning (tested by Rey Auditory Verbal Learning Test) was found only in controls. Education was significantly related to outcome in patients and age was related to outcome in controls. We conclude that neurocognitive function is relatively stable over 4.5 years in patients with long-term treated schizophrenia, in line with previous scientific research.
a b s t r a c t
Neurocognitive deficits are a core feature of schizophrenia. Deficits covering a wide range of functions have been well documented. However there is still a lack of longitudinal studies regarding the development of neurocognitive impairment. The current study examined the effect of time in longterm treated patients with schizophrenia and healthy controls on cognitive functions. A neurocognitive test-battery was administered to 36 patients and 46 controls on two occasions with approximately 4.5 years interval. Patients performed significantly worse on all measures on both occasions. The only significant decline over time was the ability to shift mental set between different rules or categories (measured by Trail Making Test B). This decline was present in both patients and controls. Improvement on attention (tested by Continuous Performance Test) was found in patients only and improvement on verbal learning (tested by Rey Auditory Verbal Learning Test) was found only in controls. Education was significantly related to outcome in patients and age was related to outcome in controls. We conclude that neurocognitive function is relatively stable over 4.5 years in patients with long-term treated schizophrenia, in line with previous scientific research. The authors discuss the impact of age and education and limitations of the study.
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Introduction
Schizophrenia is a condition that affects about one percent of the population during a lifetime worldwide (Palmer et al., 2005; McGrath et al., 2008) . Life expectancy is lower than for the general population with five percent of patients committing suicide and an increased risk for death by natural causes (Brown, 1997; Andreasen, 2000; Carlborg et al., 2010) . Schizophrenia impairs the ability to think creatively and imaginatively, to have close social relationships with other human beings, and to use language to express ideas with clarity. Even though antipsychotic medication helps the majority of patients to control the hallucinations and delusions experienced, medical treatment is less effective in reducing lack of motivation and flattened affect. The majority of patients never recover enough to return to full-time work or sustain a long-term relationship or raise a family and are left with a life-long disability. The disease counts as one of the ten most debilitating medical illnesses according to the World Health Organization (Williamsson, 2005) .
Specific cognitive function deficits associated with schizophrenia
Impaired cognitive functioning is generally considered to be a primary characteristic of schizophrenia, recognized already by both Kraepelin and Bleuler (Bozikas et al., 2006) . Five domains have been documented to be of significance in patients with schizophrenia (Lawyer et al., 2006) .
Working memory
Working memory is commonly defined as the capacity for ''temporary storage and manipulation of the information necessary for such complex cognitive tasks as language comprehension, learning and reasoning'' (Baddeley, 1992) . It has been shown by several authors that patients with schizophrenia have impaired performance on a variety of working memory tasks. These findings have also been used to support the hypothesis that the prefrontal cortex is impaired in schizophrenia spectrum patients (Gold et al., 1997; Perry et al., 2001 ).
Executive function
Executive function is a diverse collection of cognitive abilities, and refers to the ability to solve problems, use abstract concepts and manage cognitive skills and resources. Executive function also refers to the ability to effectively alternate between competing demands and adaptively shift effort in doing so (Harvey and Sharma, 2002) .
Psychomotor speed
Psychomotor speed refers to the amount of time it takes a person to process a signal, prepare a response and execute that response. This is commonly measured by reaction time. Patients with schizophrenia have slowed performance on various psychomotor measures (Morrens et al., 2007) .
Verbal memory/verbal learning
Patients with schizophrenia manifest a number of impairments in memory functions. When read a story or list of words they remember less than healthy controls (Saykin et al., 1991) . If the list or story is repeated, patients with schizophrenia learn much less than healthy controls (Davidson et al., 1996) . Still, Karilampi et al. (2007) found that 44% of patients with schizophrenia, schizoaffective disorder or delusional disorder had normal learning ability as measured by Rey Auditory Verbal Learning Test (RAVLT).
Attention/vigilance
It is well known that patients with psychosis and schizophrenia often have disturbances in attention/vigilance and that this is of great importance for their ability to retain or develop social abilities. Attentional impairments appear to persist after remission of acute psychotic episodes (Harvey and Sharma, 2002) .
Evolvement of cognitive functions over time
Neurocognitive impairments do not seem to deteriorate significantly over time, implying that schizophrenia is not likely a progressing degenerative process (Censits et al., 1997; Hoff et al., 2005) . Hoff et al. (2005) concluded that most first episode patients have had considerable cognitive decline by the time of their first hospitalization and that most cognitive change takes place early in this illness but its exact timing still remains unknown. In an earlier study by the same research group some neurocognitive improvement was found also in patients, except for verbal memory scores. No significant change in cognitive functioning was otherwise found between the patients and the healthy controls (Hoff et al., 1999) .
Some studies have investigated patients with schizophrenia and healthy controls across age groups. Fucetola et al. (2000) analyzed the effect of aging on executive functions. They discovered that patients with schizophrenia demonstrated similar age-related declines across most neuropsychological functions, with an exception of abstraction ability in which there was significant evidence of a more accelerated decline than in healthy volunteers. The authors concluded that the results indicated similar age effects on most aspects of cognition in patients with schizophrenia and healthy adults but supported the hypothesis that a degenerative process may result in a more accelerated decline of some executive functions in older age in schizophrenia (Fucetola et al., 2000) . Another study conducted by Bowie et al. (2008) found evidence for age-associated cognitive decline on the more complex components of an information processing test but not in other neuropsychological tests. These results suggest that age-related changes in cognitive function in schizophrenia may be a result of both the course of illness and the processing demands of the cognitive task of interest (Bowie et al., 2008) .
A review of 15 scientific studies of cognitive functions in schizophrenia with a follow-up period of at least one year found the majority of functions to be highly or moderately stable and some even to be improved. These functions included general IQ, verbal memory, short-term memory and attention. The only functions found to show significant decline were attention span and to a lesser degree shifting capacity (Rund, 1998) . Friedman et al. reached the same conclusion: no cognitive decline was found in patients during a follow-up period of six years (Friedman et al., 2001) . The fact that these authors singled out patients with poor prognosis made the results particularly interesting since the few studies that have been conducted with elderly patients with schizophrenia have focused on poor-outcome populations with long histories of hospitalization, possibly skewing the picture of cognitive decline over time (Harvey et al., 1999) . Further, Gold et al. (1999) found improvement in performance and full-scale IQ and no change in verbal IQ or Wisconsin Card Sorting Test (WCST) among skills during a follow-up period of five years (Gold et al., 1999) .
Taken together, the literature indicates that patients with schizophrenia generally perform worse than control subjects on all the cognitive domains described above. Generally, it seem as the cognitive decline in patients is present at onset of illness and does not deteriorate significantly during the life span. However, long-term follow up studies are few, especially in a later phase of the illness.
In a previous investigation we correlated neurocognitive measures with structural brain measures from magnetic resonance (MR) images of patients with schizophrenia using a Bayesian regression method (Lawyer et al., 2006) . The patients performed significantly worse than the controls in all neuropsychological tests except some regarding executive function (Lawyer et al., 2006) . The most prominent morphological observations were enlarged ventricles, reduced posterior superior cerebellar vermis gray matter volumes, and increased putamen gray matter volumes in the patients. Between 2005 and 2008 the patients and healthy control subjects of that study, as well as other subjects who had been investigated neuropsychologically but not had participated in the MR assessment, were asked to participate in a five-year follow-up using the same neuropsychological tests and procedures. Several of the subjects have also been included in other previous reports analyzing molecular genetics, diagnostic, personality, brain volumetric, electroencephalographic, obstetric complications and pharmacologic variations in schizophrenia and related psychosis (Jönsson et al., 2003a (Jönsson et al., ,b, c, 2006a (Jönsson et al., ,b, 2008 Ekholm et al., 2005; Agartz et al., 2006; Vares et al., 2006 Vares et al., , 2010 Vares et al., , 2011 Nesvåg et al., 2007 Nesvåg et al., , 2008 Nesvåg et al., , 2009 Kelly et al., 2008; Lawyer et al., 2008 Lawyer et al., , 2009 Saetre et al., 2008 Saetre et al., , 2010 Saetre et al., , 2011 Varnäs et al., 2008; Andreou et al., 2009; Haukvik et al., 2009 Haukvik et al., , 2010a Haukvik et al., ,b, 2012 Hartberg et al., 2010; Caprini et al., 2011; Holtze et al., 2011 Holtze et al., , 2012 Nikulin et al., 2012; Lindholm Carlström et al., 2012) .
The aim of the present study was to study putative changes of neuropsychological functions over a five-year period in the patients with schizophrenia as compared to healthy controls. Further, we aimed to explore any other factors that may be linked to the neuropsychological test results of patients with schizophrenia specifically, considering age of onset, duration of illness, number of hospitalizations and education. We hypothesized that patients and controls would be stable during the five-year period in performance with regard to the addressed cognitive functions sensitive to schizophrenia, i.e. working memory, executive function, psychomotor speed, verbal memory/learning and attention.
Methods

Ethics
The study was approved by the Ethics committee of the Karolinska Hospital. All participating subjects gave informed consent.
Subjects
The research subjects who participated in our previous studies (Lawyer et al., 2006; Hartberg et al., 2010) were drawn from a larger, previously described cohort (Jönsson et al., 2003d (Jönsson et al., , 2006b ). They were unrelated Caucasian individuals living in Stockholm County. All patients were assessed for life-time psychiatric diagnosis and geographical origin using reviews of hospital case notes, clinical and/or structured interviews, and parish register data (Ekholm et al., 2005; Vares et al., 2006) . Only patients fulfilling a DSM-III-R or DSM-IV diagnosis of schizophrenia were included. The healthy controls were drawn from a population register or recruited among hospital staff members who had previously participated in clinical studies at Karolinska Institutet as previously described (Jönsson et al., 2006b; Lawyer et al., 2006; Hartberg et al., 2010) . All reviews of hospital case notes, interviews and diagnostic formulations were performed by a psychiatrist or a psychiatry resident (Jönsson et al., 2003d) .
The patients and controls of the present study (Table 1) were recruited from a project with the aim to investigate patients with schizophrenia or schizophrenialike psychosis, relatives of patients with psychosis and control subjects with regard to several clinical, brain morphological and neuropsychological assessments (Arnborg et al., 2002) . In total 275 subjects had been investigated neuropsychologically and of those 222 were contacted via mail and telephone by a research nurse and asked to participate.
Cognitive Performance Indicator (CPI) test battery
The Cognitive Performance Indicator (CPI), a brief neuropsychological test battery was administrated as a follow-up measurement (Lawyer et al., 2006) . CPI is a semi-computerized test battery, constructed to give an overview of critical cognitive functions in patients with schizophrenia (Lawyer et al., 2006) . The tests are well known, standardized and have been used extensively in neuropsychological examinations (Table 2 ). The usability and sensitivity to cognitive deficits generally displayed by patients with schizophrenia are the main reasons for choosing this test battery. In CPI, the administration of subtests and the registration of data are guided by a computer program, which makes it easy to use in clinical as well as research settings. CPI comprises Rey Auditory Verbal Learning (Heaton et al., 1993; Lezak, 1995; Wechsler, 1997) .
In the present study, five of the six domains from the CPI test battery were used to investigate the performance of patients and healthy controls. The Vocabulary from WAIS-R used in the previous investigation was excluded since it is regarded as a ''hold test'' for roughly assessing pre-morbid functional level.
Data analysis
A 2 Â 2 repeated analysis of variance (ANOVA) was conducted with the first factor being group (patients or controls) and the second factor being time (baseline or follow-up) and the dependent variable being the 17 test scores. These analyses were performed both without and with education (years of schooling) as a covariate. A paired-samples t-test was calculated for the within group scores of the 17 tests to see if the eventual significant main effect of time was based on one groups' significant difference and not the others.
For the three demographic variables available for both groups (sex, age and years of education) an independent samples t-test was conducted for significant differences between groups. All three variables were then correlated to the 17 mean scores for each group at both baseline and follow-up using Pearson's and Spearman's correlations with two-tailed significance. Each of the remaining demographic variables (age of onset, illness duration and number of hospitalizations) were then correlated with the 17 test scores for patients at baseline and follow-up to see if any significant correlations would appear, using Pearson's correlation with two-tailed significance. We set the alpha level to 0.05 for all statistical analysis.
Results
The attrition rate was 0.39, 0.16, 0.42 and 0.39 among male cases, female cases, control men and control women, respectively. Among the 74 patients who declined to participate the reasons were: rejected participation (n ¼39), no contact (n¼27), dead (n¼ 3), moved out of the area (n ¼5). Reasons for drop-out among the 66 controls were: no available time (n ¼23), rejected participation (n¼23), no contact (n ¼16), moved out of the area (n ¼4). There was a significantly higher drop-out rate among women with schizophrenia than male cases, control women, and control men (p o0.02). Participating patients and controls tended to be younger than patient drop-outs and control drop-outs (p ¼0.07 and p ¼0.03), respectively. There were no significant different scores of Global Assessment of Functioning (GAF) (American Psychiatric Association, 2000) or the WAIS vocabulary test either among participating or non-participating patients or participating or control drop-outs (all p 40.3). However, patients who participated in the follow-up tended to perform better in the subtests RAVLT 1 (p ¼0.05), RAVLT 2 (p ¼0.09), RAVLT Total (p ¼0.08), RAVLT B (p¼0.08), CPT (p ¼0.08), TMTA (p ¼0.03), TMTB (p ¼0.09) and LNS (p ¼0.05) than drop-out patients. Controls who participated tended to perform better in the subtests RAVLT B (p ¼0.02) and TMTB (p ¼0.08) than control drop-outs. Among the patients there were no significant differences with regard to age at onset of illness, number of hospitalizations, or medication as mirrored by antipsychotic equivalents (Woods, 2003) between participants and drop-outs. All patients who participated in the study had sometime been prescribed antipsychotics, but three and six did not take antipsychotics at base-line or at follow-up, respectively.
There was a significant difference between groups on all test scores at baseline (Table 3 ; 0.000 op o0.05). Likewise, there was a significant difference between groups on all test scores at follow-up (Table 3 ; 0.000op o0.05).
Results of the ANOVA showed that for RAVLT 1 there was a significant main effect of time (p¼0.003) as well as a significant main effect of group (p ¼0.0001). There was also a significant interaction time/group effect where the controls performed better than patients at both times but more so during the second testing (p ¼0.028). On RAVLT 2 there was also a significant main effect of time (p¼ 0.002). On CPT there was a significant main effect of time (p ¼0.008) and the same result was found for TMT B (p ¼0.0001).
We also performed the calculations above taking the effect of education into account (Table 3 ). The results remained essentially similar, but the effect of time in the analyses concerning RAVLT 1, RAVLT 2, CPT and TMTB was no longer significant, and an effect with regard to time on TMTA became significant (p ¼0.03).
The controls had significantly increased their scores on the first two trials of RAVLT (p ¼0.0001) whereas the patients had not (Table 4 ). The controls also showed a significant increase in the total score of RAVLT (p ¼0.013) as opposed to the patients. Fig. 1 
Table 3
Comparison between neuropsychological test results in patients with schizophrenia and control subjects at base-line and at follow-up after five years (ANOVA). Mean raw scores (standard deviation in brackets) and F-values for main effect of group, time, and interaction group/time with or without entering education (years of schooling) as a covariate. presents an overview of the learning curves of patients and controls at baseline and follow-up, respectively. The patients showed a significant increase on the CPT (p¼0.035). Both patients and controls show a significant decrease in performance on the TMT B over time (patients p ¼0.017, and controls p ¼0.006) ( Table 4) .
The patients performed significantly below the controls at both baseline and follow-up (Fig. 2) . The patients' standard deviation scores ranged from at best À 0.57 (WCST-TC) to at worst À 2.29 (RAVLT 5) at baseline, and from at best À 0.46 (CPT) to at worst À 2.34 (RAVLT 5) at follow-up, when compared to controls.
Significant correlations were found for a range of tests and education for patients but less so for controls (Table 5) . For controls test results correlated more with age than for patients with the exception of WCST. Illness duration correlated only with aspects of WCST.
No significant correlations were found for the variables ''Age of onset'' or ''Number of hospitalizations'' either at baseline or follow-up for patients (Table 5) . With the exception of LNS no correlations were found for ''Education at baseline'' for controls (Table 5) .
Discussion
The main finding of this study shows that cognitive performance over time in patients with schizophrenia does not deteriorate compared to a control group. However, some differences were found which will be discussed as follows.
Rey Auditory Verbal Learning Test (RAVLT)
The controls showed a significant increase in RAVLT trial 1, 2 and Total scores whereas the patients did not. On RAVLT 1 there was a significant interaction effect of time/group which indicates that controls performed better than patients at both times and significantly more so at follow-up. Rather than reflecting a real change in verbal memory this might imply that controls had a better advantage of having taken the test at baseline than patients. Some research shows that healthy controls have a small but statistically significant practise effect in longitudinal studies over a period ranging from six months to one year (Mitrushina et al., 2005) . The patients did not perform significantly worse on any RAVLT score between the two test occasions indicating stability over time in verbal memory, which is consistent with earlier research .
For the same scores of RAVLT 1, 2 and Total there was a significant correlation with age for the control group but not for the patients. Previous studies have consistently demonstrated an effect of age on recall tested by RAVLT in healthy controls (Mitrushina et al., 2005) and the current findings for healthy controls are as expected. The same correlation is not found for the patient group possibly implying that the illness effect may dominate over the normal effects of ageing.
For the control group, we found a significant correlation between education at follow-up and RAVLT 3 only. For the patients however, significant correlations between education at baseline and RAVLT 5 and Total were found. In addition, there was a significant correlation between education at follow-up and RAVLT 1, 3, 4, 5, Total and list B. The results suggest that education is of greater importance in maintaining neuropsychological function in patients with schizophrenia than in the healthy population.
Continuous Performance Test (CPT)
Patients significantly improved their performance on CPT at follow-up whereas the controls did not. This is in contrast to a previous study, which reported neither significant improvement nor decline over time in patients or controls on CPT (Censits et al., 1997) . However, a more recent report concluded that most patients' attention is stable over time and if there is a change, it tends to be positive rather than negative, which renders our findings reasonable (Liu et al., 2006) .
Older age has been associated with worse performance on CPT (Chen et al., 1998; Birkett et al., 2007) . Our results replicate this association in the healthy controls but not among patients, suggesting that the effect of schizophrenia obscure the normal effect of ageing on functions measured by CPT. Likewise, education has been linked to performance on CPT with more years of education yielding better performance (Chen et al., 1998) . We found this to be the case for the patient group but not for the controls whose CPT performance results did not show any correlation with education. This is in accordance with the results from RAVLT in this study, suggesting that education enhances test performance among patients.
Trail Making Test (TMT)
Both controls and patients showed significant decline on TMT B over time. The association between older age and poorer TMT scores has been found among both controls and patients but appears to be of smaller magnitude in cases with brain injury (Mitrushina et al., 2005) . In our data the significant decline in scores is larger in controls than in patients, which supports the above mentioned notion.
Earlier research has found a relationship between TMT and education, where higher level of education is linked to better test performance in normal individuals (Mitrushina et al., 2005) . The present study failed to replicate this result. However, this relationship was found in the patient group where patients with more extended education outperformed those with fewer years of education. As was the case of the correlations between education and RAVLT, this might propose that education is of more importance for the patient group than the control group, perhaps as a mitigating or protective factor against cognitive decline.
Letter-Number-Sequencing (LNS)
There was no significant decline in LNS scores for either group. This indicates that no improvement or decline in working memory occurred within either group. Performance on LNS has been reported to be highly dependent on both age and education (Mitrushina et al., 2005) so a relationship should be expected. For the patients a significant correlation was found with education but not for age, and for the controls a significant correlation with education was found at baseline but not at follow-up. For neither groups there were any correlations with age. This is interesting since our sample is relatively well distributed over both age and education in both groups. It might be that our sample of controls is too small to generally detect these Table 5 Significant correlations between neuropsychological test-scores and years of education, age or illness duration in patients with schizophrenia (Pat) and control subjects (Con) at baseline or five years follow-up. Analyses were also performed for patients with regard to age at onset of illness and number of hospitalizations without significant results. relationships, but it might also strengthen our previously described hypothesis of education being more important for patients' later cognitive performance compared to controls.
Test
Wisconsin Card Sorting Test (WCST)
Neither group showed any significant difference in results from baseline to follow-up on any of the WCST scores. This is in line with earlier research (Censits et al., 1997; Gold et al., 1999) . However, it should be noted that only a few longitudinal studies have examined WCST performance in patients with schizophrenia.
In previous studies, there is a well documented negative effect of age on the WCST but age seems to become a relevant factor only after approximately 60 years or even later (Mitrushina et al., 2005) . In our study we found that controls' age and WCST correlated significantly at baseline for perseverative errors and perseverative responses but this correlation was lost at follow-up. In our patient group however, age correlated with three of four WCST scores at baseline and all four at follow-up, indicating that older patients performed worse than younger at both times. Since the mean age did not differ significantly between cases and controls this suggests that the ageing process might speed up cognitive decline in patients but not in controls.
There is a similar effect of education on WCST in the normal population where its effect is most evident after 15 years of formal education (Mitrushina et al., 2005) . Since both our groups had mean education levels lower than 15 years it was not predicted to have a strong effect. What we found is that once again, in the patient group there were significant correlations between education and WCST but less so among the controls. This has been found in some other studies regarding education and WCST (Mitrushina et al., 2005) .
There is no clear evidence regarding the effects of illness duration on WCST, with some studies reporting relationships and some not (Mitrushina et al., 2005; Vega et al., 2005) . We found a correlation between illness duration and three of four scores from WCST at follow-up for patients while controlling for age, indicating that patients perform worse with elapsed illness.
It would be very interesting to follow this cohort over an extended period of time to investigate the stability of cognitive functions. Whether this stability is life-long, deteriorates later in life or perhaps renders patients with schizophrenia more vulnerable to dementias are questions that remain to be answered.
Limitations
The present results should be considered against certain aspects that may have influenced our findings. In contrast to most other follow-up investigations the patients of the present study were long-term treated already at the base-line assessment. This means that the results of the present study are not representative for patients in their early phase of illness. The sample of patients was also not controlled for the type of medication used and so there was a variety of different medications represented in the patient sub-sample. However, there was no correlation (r 2 o0.02) between measures of neuroleptic equivalents and attention among patients, suggesting that this kind of medication did not severely affected the outcome. Regarding the relevance of the selection of neuropsychological tests used, they were selected among well-known reliable and valid tests tapping the functional domains most often compromised in schizophrenia, according to the literature. For this reason we consider the chosen tests to be adequate measures for the study of neuropsychological functions in patients with schizophrenia.
The attrition rate was high and subsequently the number of patients and controls included in the study was limited, lowering the statistical confidence. However, high drop-out rates is common in demanding follow-up studies performed several years apart. The current sample of patients had a skewed gender distribution with significantly less women than men compared to the control group. There have been studies conducted that show no robust gender differences in neuropsychological performance of patients with schizophrenia (Hoff et al., 1998) . Still, we cannot rule out that the relatively larger proportion of women among controls might have implications for our results, because previous studies have shown a small but relatively constant advantage for women on verbal learning tests (Reite et al., 1993; Mitrushina et al., 2005) and more specifically on RAVLT (Messinis et al., 2007) .
The educational level of controls and of patients was skewed with the controls having an average of more than one year of additional education. However, the results remained overall similar after taking education into account in the analyses. Occupation, and whether the patients were working and to what extent were not controlled for, which are also factors to take into consideration.
Summary and conclusions
Overall, our results confirm the findings from previous studies of longitudinal change in neuropsychological functioning in patients with schizophrenia pointing to an essentially stable course (Censits et al., 1997; DeLisi and Hoff, 2005) . The broad age range of the patients in the present study mirroring particularly a late-phase of this disorder, suggest that an intervention to prevent cognitive decline -if it is possible -is needed to take place early in the course of the disorder. The patients show a cognitive profile that is well below what was found in the control subjects across a range of tests at both baseline and follow-up, but no significant decline has occurred over time compared to healthy controls. The patients have significantly improved their score on CPT and the controls have significantly improved their scores on RAVLT trials 1, 2 and Total. Both groups have decreased their scores on TMT B. We also found significant correlations between neuropsychological measures and education for patients but much less so among controls. This was an unexpected finding and further research regarding this topic might be of interest. Furthermore, the effect of age was more prominent for the controls than patients except for the WCST scores for which the opposite relationship was found.
The present results point to a relationship between education and cognitive test performance among patients but not among controls. One must bear in mind that the relationship is not determined in any one direction, so it might be that patients with better cognitive functioning from the beginning were able to acquire longer education and therefore also perform better on CPI, and not necessarily that education per se is a protective factor, although there is some research suggesting that conclusion (Vega et al., 2005) . The correlation becomes more interesting when one finds that the usual correlation between performance on tests and education in the healthy population was not found in our sample to the expected degree. In part this might be due to the relatively small sample. However, many reports have fewer participants than ours and so we consider this topic to be of interest to further investigate.
Generally, performance on cognitive tests becomes worse with older age. This is the case for the controls but not the patients of the present study, a result that is to some extent supported by previous investigators (Vega et al., 2005) . The present results give further support to the notion that schizophrenia as an illness might obscure the normal decline in age related performance seen in controls.
